Invest PortfolioEventsRaise Funds
Capital at risk.Please read risk warning.

AgPlus Diagnostics

Equity
EIS

A quantitative Point of Care platform which enables faster, more accurate diagnosis and targeted treatment.

Target
£1,600,000


Invested
£1,057,005


Investments
2

£

This is not a commitment. You will be asked to confirm in the next section.

Contact

Companies house

Twitter

Overview

AgPlus has developed a game changing diagnostic platform for detection of human diseases which delivers laboratory instrument results at the point of care, addressing both market requirements and currently unmet needs.

USP’s for AgPlus are full quantitation, high sensitivity and multi-sample and analyte capability. These enable medical professionals to match the right drug with the right patient at the right time, improving patient quality of life.

AgPlus is working in collaboration with leading diagnostics companies to develop and distribute products rapidly and globally. This model enables greater reach and scalability of the AgPlus platform.

Since launching this funding round in September 2019, AgPlus has secured 2 major new clients, and has joined the race to produce a point of care test specific for Covid-19.  The test will be able to determine Covid-19 infection within 10 minutes close to a patient and outside a laboratory. It will come in three formats: for early detection of the virus, to monitor infection progress and to detect antibodies against the virus.
 

Jessica Wilson

Deal Manager

Sector:

Healthcare

Country:

United Kingdom

Stage:

Established (substantial revenues, pre-profit)

Valuation:

£4,700,000

Share price:

£6.40

Team

This section is currently locked.

Please Sign Up or Log In to unlock.

Market

This section is currently locked.

Please Sign Up or Log In to unlock.

Investment

This section is currently locked.

Please Sign Up or Log In to unlock.

Updates

This section is currently locked.

Please Sign Up or Log In to unlock.

Questions

This section is currently locked.

Please Sign Up or Log In to unlock.

Documents

17 document(s) hidden

Originator

Originator: Envestors

Contact name: Oliver Woolley

Investment Focus: Equity, Debt

About: Envestors is a FCA regulated corporate finance adviser in the UK and operates an international network of sophisticated investors investing an average of £42,000 in high growth unquoted companies seeking £250,000 to £2m in equity funding.

Over 1000

Experienced investors

Over £100m

Funding raised

ABOUT

Envestors is a FCA regulated corporate finance adviser in the UK and operates an international network of sophisticated investors investing an average of £42,000 in high growth unquoted companies seeking £250,000 to £2m in equity funding.

FURTHER INFORMATION

DisclaimerPrivacy PolicyRisk Warning

IMPORTANT INFORMATION

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Envestors does not provide specific individual advice on the suitability of investments with regard to a potential investor's individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.Please click here to see the full Risk Warning.

© 2020 Envestors. All rights reserved.

Powered by ENVESTRY

Sqreen | Runtime Application Protection

By using our site, you acknowledge that you have read and understand our Privacy and Cookie Policy